Professor Hubert Hondermarck

  • Professor
    School of Biomedical Sciences and Pharmacy
    College of Health, Medicine and Wellbeing
  • Focus area: Medical Biochemistry

News

MHF Centre for Brain Cancer Research Symposium WIDGET

News • 9 Jun 2023

Symposium spurs race to beat brain cancer

Experts from across the nation are tackling brain cancer head on with collaboration front and centre following the inaugural symposium of the University of Newcastle’s Mark Hughes Foundation Centre for Brain Cancer Research.

News • 7 Mar 2019

Mark Hughes Foundation awards innovation in brain cancer

Five highly innovative brain cancer research projects have received over $725,000 in funding from the Mark Hughes Foundation (MHF) following a nationwide call-out and scientific review by experts in the field.

Image featuring 3 men. Top left, Man with short light well styled hair is smiling to camera. Top right, Man with short dark tousled hair smiles to camera. Bottom, Man with close cropped grey hair wearing glasses sits before scientific equipment smiling at camera.

News • 31 Jan 2025

Three Tour de Cure Grants awarded

We’re delighted to announce that three researchers in the Mark Hughes Foundation Centre for Brain Cancer Research have been awarded funding in the 2024/2025 Tour de Cure grant round.

Hubert Hondermarck

News • 27 Mar 2017

Study strikes a nerve with the spread of cancer

A group led by University of Newcastle biochemistry researcher Hubert Hondermarck has found parallels between tissue regeneration, nerve growth and tumour development, confirming for the first time that the nervous system is strongly implicated in the onset and spread of cancer.

News • 18 Dec 2019

NHMRC awards $9.3 million to 13 University of Newcastle projects

The University of Newcastle has received more than $9.3 million in funding to support projects aiming to solve some of the world’s most critical health problems and improve the lives of millions of Australians.

Nathan Barlett and Hubert Hondermarck in a labratory looking at the camera

News • 16 Apr 2020

Drug repurposing potential for COVID-19

The COVID-19 pandemic has highlighted the need for anti-viral therapies to treat respiratory virus infections. With a vaccine probably at least 12 months away, drug repurposing (using clinically approved drugs which also have anti-viral activity) offers hope in fast-tracking therapies to possibly treat infected people and save lives.

Professor Hubert Hondermarck

News • 15 Mar 2019

Research underway to improve prostate cancer diagnosis

Early research findings have indicated that a simple blood test may provide a more accurate way of identifying aggressive prostate cancers, which could result in more immediate treatment for men with high-risk disease and reduce unnecessary procedures for men with benign or low-risk tumours.

Spinal cord research

News • 15 Dec 2022

Spinal cord pain to PTSD: $5.2m in NHMRC grants to target pressing medical conditions

Both the body and the mind will be a key focus for innovative researchers from the University of Newcastle, who were successful in the latest round of National Health and Medical Research Council (NHMRC) Ideas Grants.

Picture of Professor Hubert Hondermarck, wearing a blue button up collared shirt with his arms crossed, in a laboratory.

News • 11 Apr 2025

New funding for targeted therapy in glioblastoma

Professor Hubert Hondermarck has been awarded Cancer Council funding of $439,533 for a translational research project to develop a targeted therapy to treat glioblastoma (GBM) – a deadly form of brain cancer with no effective treatments.